Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Bear

posted on May 15, 2020 03:25PM

Sarah just emailed me that Zenith will publish their poster at AACR on June 22nd and then it will be posted on the company website

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply